Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-ADCs and PROTACs-PROTAC-RP03707
RP03707

Chemical Structure : RP03707

CAS No.: 3030493-05-8

RP03707

Catalog No.: PC-24575Not For Human Use, Lab Use Only.

RP03707 is a CRBN-involving, highly potent, and selective KRAS G12D PROTAC degrader with DC50 of 0.7 nM in PK-59 cells (Dmax=96%).

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

RP03707 is a CRBN-involving, highly potent, and selective KRAS G12D PROTAC degrader with DC50 of 0.7 nM in PK-59 cells (Dmax=96%).
RP03707 has a DC50 value of 0.6 nM for KRASG12D degradation, and pERK inhibition IC50 of 2.5 nM in AsPC-1 cells.
RP03707 exhibits no degradation activity against other RAS isoforms, including NRAS and HRAS, KRAS WT.
RP03707 also exhibits no degradation of IKZF1/3, in stark contrast to the positive control pomalidomide that showed expected IKZF1/3 depletion.
RP03707 exhibits a generally stronger antiproliferative effect against cancer cell lines carrying the KRASG12D mutant relative to MRTX1133.
RP03707 induces the degradation of both the active form and inactive forms of KRASG12D proteins concurrently in cells.
RP03707 (0.1-3 mg/kg, i.v.) exhibited significant antitumor effects with tumor growth inhibition (TGI >90%) in KRASG12D tumor-bearing mice.

Physicochemical Properties

M.Wt 994.14
Formula C55H58F3N11O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-[6-[1-[7-[[1-[[4-(3,8-Diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoro-3-hydroxy-1-naphthyl)-8-fluoro-pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]cyclopropyl]methyl]-7-azaspiro[3.5]nonan-2-yl]-4-piperidyl]-5-fluoro-1-methyl-indazol-3-yl]hexahydropyrimidine-2,4-dione

References

1. Ji X, et al. J Med Chem. 2025 May 8. doi: 10.1021/acs.jmedchem.5c00428.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: